Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04313114 · ClinicalTrials.gov registry record · NA
The PRIME-CRC Trial to Promote CRC Screening in Rural Communities
A NA study of Colorectal Cancer, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Active
- Registry status
- NA
- Development phase
- 804
- Enrollment target
- 3
- Study locations
NCT04313114: Active NA study of Colorectal Cancer, sponsored by Louisiana State University Health Sciences Center Shreveport.
NCT04313114 is a NA study of Colorectal Cancer that is active but no longer recruiting, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 804 participants, below the 1,509-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (47% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04313114, a NA study of Colorectal Cancer, is active but no longer recruiting, sponsored by Louisiana State University Health Sciences Center Shreveport.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 804 participants
- Enrollment target
- 3
- Study locations
Study Summary
The investigators will expand an existing, patient-centered, health literacy strategy to promote longer-term adherence to colorectal cancer (CRC) screening in resource-limited, rural health clinics via colonoscopy or annual fecal immunochemical test (FIT). In the proposed 2-arm study, both PRIME-CRC and enhanced usual care (control) will incorporate health literacy evidence-based practices for delivering CRC patient information and counseling to aid patient decision making for selecting FIT or colonoscopy, including simplified test instructions. In addition, the PRIME-CRC arm will use a "stepped care" approach for reminding patients on proper CRC screening preparation for scheduled colonoscopy or completion of annual FIT. Patients in the PRIME-CRC arm will receive frequent follow-up contact from their health care provider via audio-recorded, automated call or SMS text, based on patient preference.
Conditions Studied
Interventions
- BEHAVIORAL health literacy appropriate education and demonstration
- BEHAVIORAL shared decision making
- BEHAVIORAL automated call reminders or automated texts
Study Locations (3)
Louisiana
- CommuniHealth (dba Morehouse Community Medical Centers, Inc.) - Bastrop
- CommuniHealth (dba Morehouse Community Medical Centers, Inc.) - Marion
- Tensas Community Health Centers - Saint Joseph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 804 participants |
| Start Date | 2021-09-20 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04313114
The ClinicalTrials.gov registry entry for NCT04313114 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 804 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,509-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (47% lower). The listed sponsor is Louisiana State University Health Sciences Center Shreveport, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 3 interventions - of which health literacy appropriate education and demonstration is the first listed.
NCT04313114 reports 3 study locations spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT04313114 about?
NCT04313114 is a clinical study titled "The PRIME-CRC Trial to Promote CRC Screening in Rural Communities". The investigators will expand an existing, patient-centered, health literacy strategy to promote longer-term adherence to colorectal cancer (CRC) screening in resource-limited, rural health clinics via colonoscopy or annual fecal immunochemical test (FIT). In the proposed 2-arm study, both PRIME-CRC...
What is the current status of trial NCT04313114?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 804 participants. The study started on 2021-09-20. Estimated completion is 2026-05-31.
What conditions does trial NCT04313114 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT04313114?
The interventions under investigation include: health literacy appropriate education and demonstration (BEHAVIORAL), shared decision making (BEHAVIORAL), automated call reminders or automated texts (BEHAVIORAL).
Who is sponsoring clinical trial NCT04313114?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04313114 being conducted?
This trial has 3 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.